Original Work

602.

Reshef, A.⁺, Buttgereit, T., Betschel, S. D., Caballero, T., Farkas, H., Grumach, A. S., Hide, M., Jindal, A. K., Longhurst, H., Peter, J., Riedl, M. A., Zhi, Y., Aberer, W., Abuzakouk, M., Al Farsi, T., Al Sukaiti, N., Al-Ahmad, M., Altrichter, S., Aygören-Pürsün, E., Baeza, M. L., Bara, N. A., Bauer, A., Bernstein, J. A., Boccon-Gibod, I., Bonnekoh, H., Bouillet, L., Brzoza, Z., Bygum, A., Calderon, O., de Albuquerque Campos, R., Campos Romero, F. H., Cancian, M., Chong-Neto, H. J., Christoff, G., Cimbollek, S., Cohn, D. M., Craig, T., Danilycheva, I., Darlenski, R., Du-Thanh, A., Ensina, L. F., Fomina, D., Fonacier, L., Fukunaga, A., Gelincik, A., Giavina-Bianchi, P., Godse, K., Gompels, M., Goncalo, M., Gotua, M., Guidos-Fogelbach, G., Guilarte, M., Kasperska-Zajac, A., Katelaris, C. H., Kinaciyan, T., Kolkhir, P., Kulthanan, K., Kurowski, M., Latysheva, E., Lauerma, A., Launay, D., Lleonhart, R., Lumry, W., Malbran, A., Ali, R. M., Nasr, I., Nieto-Martinez, S., Parisi, C., Pawankar, R., Piñero-Saavedra, M., Popov, T. A., Porebski, G., Prieto Garcia, A., Pyatilova, P., Rudenko, M., Sekerel, B. E., Serpa, F. S., Sheikh, F., Siebenhaar, F., Soria, A., Staevska, M., Staubach, P., Stobiecki, M., Thomsen, S. F., Triggiani, M., Valerieva, A., Valle, S., Van Dinh, N., Vera Ayala, C. E., Zalewska-Janowska, A., Zanichelli, A., Magerl, M., and Maurer, M.: The definition, acronyms, nomenclature, and classification of angioedema: AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus. J. Allergy Clin. Immunol. 2024: 154; 398-411. IF: 11.20

601.

Casale, T. B.⁺, Trzaskoma, B., Holden, M., Bernstein, J. A., and Maurer, M.: Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab? World Allergy Organ. J. 2024: 17; 100943. IF: 4.30

600.

Hu, M., Scheffel, J., Frischbutter, S., Steinert, C., Reidel, U., Spindler, M., Przybylowicz, K., Hawro, M., Maurer, M., Metz, M.^*, and Hawro, T.^+*: Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas. Clin. Exp. Med. 2024: 24; 171. IF: 3.50

598.

Maurer, M.⁺, Casale, T. B., Saini, S. S., Ben-Shoshan, M., Giménez-Arnau, A. M., Bernstein, J. A., Yagami, A., Stjepanovic, A., Radin, A., Staudinger, H. W., Patel, N., Amin, N., Akinlade, B., Fan, C., Bauer, D., Yancopoulos, G. D., Patel, K., Mannent, L. P., and Laws, E.: Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials. J. Allergy Clin. Immunol. 2024: 154; 184-194. IF: 11.20

597.

Pyatilova, P., Hackler, Y., Aulenbacher, F., Asero, R., Bauer, A., Bizjak, M., Day, C., Dissemond, J., Du-Thanh, A., Fomina, D., Giménez-Arnau, A., Grattan, C., Gregoriou, S., Hawro, T., Kasperska-Zajac, A., Khoshkhui, M., Kocatürk, E., Kovalkova, E., Kulthanan, K., Kuznetsova, E., Makris, M., Mukhina, O., Pesqué, D., Peter, J., Salameh, P., Siebenhaar, F., Sikora, A., Staubach, P., Tuchinda, P., Zamłyński, M., Weller, K., Maurer, M., and Kolkhir, P.⁺: Non-skin-related symptoms are common in chronic spontaneous urticaria and linked to active and uncontrolled disease: results from CURE. J. Allergy Clin. Immunol. Pract. 2024: 12; 1890-1899. IF: 6.60

596.

Riedl, M. A.⁺, Farkas, H., Aygören-Pürsün, E., Psarros, F., Soteres, D. F., Staevska, M., Cancian, M., Hagin, D., Honda, D., Melamed, I., Savic, S., Stobiecki, M., Busse, P. J., Dias de Castro, E., Agmon-Levin, N., Gower, R., Kessel, A., Kurowski, M., Lleonart, R., Grivcheva Panovska, V., Wedner, H. J., Audhya, P., K., Hao, J., Iverson, M., Smith, M. D., Yea, C. M., Lumry, W. R., Zanichelli, A., Bernstein, J. A., Maurer, M., and Cohn, D. M., for the KONFIDENT investigators: Oral sebetralstat for on-demand treatment of hereditary angioedema attacks. New Engl. J. Med. 2024: 391; 32-43. IF: 78.50

595.

Conti, D. M.⁺, Backer, V., Beyer, K., Bjermer, L., Chaker, A., Dramburg, S., Gaga, M., Gappa, M., Gevaert, P., Hamelmann, E., Hellings, P. W., Jesenak, M., Kopp, M., Maurer, M., Podesta, M., Ryan, D., Scadding, G., Wüstenberg, E., Wahn, U., and Lau, S.: EUFOREUM Berlin 2023: optimizing care for type 2 inflammatory diseases from clinic to AI: a pediatric focus. Pediatr. Allergy Immunol. 2024: 35; e14183. IF: N/A

594.

Siiskonen, H., Fok, J. S., Buscone, S., Castellano Pellicena, I, Uzunbajakava, N., Botchkareva, N., Maurer, M.⁺, and Scheffel, J.: Human skin mast cells express photoreceptors. J. Eur. Acad. Dermatol. Venereol. 2024: 38; 629-631. IF: 8.00

593.

Ali, Z.⁺, Sørensen, J. A., Zhang, D. G., Ghazanfar, M. N., Allerup, J. A. C., Maurer, M., Kocatürk, E., Vestergaard, C., and Thomsen, S. F.: Smartphone photographs of chronic urticaria taken by patients are of good quality and useful in the clinic. Dermatology 2024: 240; 357-361. IF: 2.70

592.

Grekowitz, E., Metz, M., Altrichter, S., Bauer, A., Brockow, K., Heine, G., Lionnet, L., Kaplan Saday, K., Hultsch, T., Soerensen, O., and Maurer, M.⁺: Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase 2a, randomised, double-blind, placebo-controlled, multicentre, crossover trial. Br. J. Dermatol. 2024: 190; 825-835. IF: 9.60